Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 3/2010

01-12-2010 | Original Article

Continuous Cardiac Output and Near-Infrared Spectroscopy Monitoring to Assist in Management of Symptomatic Cerebral Vasospasm After Subarachnoid Hemorrhage

Authors: Tatsushi Mutoh, Tatsuya Ishikawa, Akifumi Suzuki, Nobuyuki Yasui

Published in: Neurocritical Care | Issue 3/2010

Login to get access

Abstract

Background

Hemodynamic augmentation by increasing cardiac output with dobutamine (DOB) is believed to be a useful method of elevating decreased cerebral blood flow in the territory affected by vasospasm following aneurysmal subarachnoid hemorrhage (SAH). We described the clinical utility of uncalibrated radial artery-based pulse contour cardiac output (APCO) and near-infrared spectroscopy regional cerebral oxygen saturation (rSO2) monitoring for reversing vasospasm symptoms with DOB-induced hyperdynamic therapy.

Methods

Seven consecutive patients who underwent surgical clipping within 24 h of SAH onset and subsequently developed delayed ischemic neurological deficits attributable to vasospasm were investigated. They were treated with DOB administered at a dose of 3 μg/kg/min and then increased in 3 μg/kg/min increments until resolution of the symptoms. Continuous APCO and rSO2 measurements in conjunction with the assessment of clinical courses and outcomes were performed.

Results

In spasm-affected territories, decreased and/or fluctuating rSO2 was detected at baseline compared with recordings in other brain regions. Patients who exhibited rapid elevation of APCO in response to an incremental dose of DOB had subsequent uptake and stabilization of rSO2 followed by improvement of vasospasm-related clinical symptoms with a maximal dose of DOB, resulted in favorable functional outcomes thereafter. A fairly strong relationship was found between peak APCO slope and rSO2 elevation, with a significantly high area under the receiver operating characteristic curve predicting neurological improvement with DOB treatment.

Conclusions

Our clinical experience indicates that integrative monitoring with APCO and rSO2 may provide continuous, real-time, and clinically relevant information on the effectiveness of medical treatment of distal vessel vasospasm.
Literature
1.
2.
Sen J, Belli A, Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2(10):614–21.CrossRefPubMed
3.
Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387–96.CrossRefPubMed
4.
Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, american heart association. Stroke. 2009;40(3):994–1025.CrossRefPubMed
5.
Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35(8):1844–51.CrossRefPubMed
6.
Hadeishi H, Mizuno M, Suzuki A, Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo). 1990;30(5):317–23.CrossRef
7.
Joseph M, Ziadi S, Nates J, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53(5):1044–51. discussion 1051–42.PubMed
8.
Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1993;79(4):494–9.CrossRefPubMed
9.
Mutoh T, Ishikawa T, Nakase T, et al. Impact of early goal-directed hemodynamic optimization on clinical management and outcome after subarachnoid hemorrhage: a prospective controlled study. Neurology. 2010;74(9 suppl 2):130.
10.
Scheeren TW, Wiesenack C, Compton FD, et al. Performance of a minimally invasive cardiac output monitoring system (FloTrac/Vigileo). Br J Anaesth. 2008;101(2):279–80.CrossRefPubMed
11.
Oddo M, Milby A, Chen I, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(4):1275–81.CrossRefPubMed
12.
Zada G, Terterov S, Russin J, et al. Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen. Neurocrit Care. 2009;12(2):265–8.CrossRef
13.
Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92.CrossRefPubMed
14.
Mutoh T, Kazumata K, Ajiki M, et al. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke. 2007;38(12):3218–24.CrossRefPubMed
15.
Naidech A, Du Y, Kreiter KT, et al. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery. 2005;56(1):21–7.PubMed
16.
Yoshitani K, Kawaguchi M, Miura N, et al. Effects of hemoglobin concentration, skull thickness, and the area of the cerebrospinal fluid layer on near-infrared spectroscopy measurements. Anesthesiology. 2007;106(3):458–62.CrossRefPubMed
17.
Kishi K, Kawaguchi M, Yoshitani K, et al. Influence of patient variables and sensor location on regional cerebral oxygen saturation measured by INVOS 4100 near-infrared spectrophotometers. J Neurosurg Anesthesiol. 2003;15(4):302–6.CrossRefPubMed
18.
Calderon-Arnulphi M, Alaraj A, Slavin KV. Near infrared technology in neuroscience: past, present and future. Neurol Res. 2009;31(6):605–14.CrossRefPubMed
19.
Mutoh T, Kazumata K, Ishikawa T, Terasaka S. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Stroke. 2009;40(7):2368–74.CrossRefPubMed
20.
Mutoh T, Ishikawa T, Yasui N. Application of the FloTrac arterial pressure-based continuous cardiac output monitor to dobutamine-induced hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage. No Shinkei Geka. 2009;37(11):1085–93.PubMed
21.
Mutoh T, Ishikawa T, Nishino K, Yasui N. Evaluation of the FloTrac uncalibrated continuous cardiac output system for perioperative hemodynamic monitoring after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2009;21(3):218–25.CrossRefPubMed
22.
Aaslid R. Development and principles of transcranial Doppler. In: Newell DW, Asalid R, editors. Transcranial Doppler. New York, NY: Raven Press; 1992. p. 1–8.
23.
Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100(1–2):12–24.CrossRef
24.
25.
Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med. 2002;30(6):1348–55.CrossRefPubMed
26.
Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001;32(10):2292–8.CrossRefPubMed
27.
Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke. 2009;40(6):1963–8.CrossRefPubMed
28.
Naidech AM, Bendok BR, Ault ML, Bleck TP. Monitoring with the somanetics invos 5100c after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;9(3):326–31.CrossRefPubMed
29.
Ekelund A, Kongstad P, Saveland H, et al. Transcranial cerebral oximetry related to transcranial doppler after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1998;140(10):1029–35 (discussion 1035–26).CrossRef
30.
Rothoerl RD, Faltermeier R, Burger R, et al. Dynamic correlation between tissue po2 and near infrared spectroscopy. Acta Neurochir Suppl. 2002;81:311–3.PubMed
31.
Luer MS, Dujovny M, Slavin KV, et al. Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report. Neurosurgery. 1995;36(5):1033–6.CrossRefPubMed
Metadata
Title
Continuous Cardiac Output and Near-Infrared Spectroscopy Monitoring to Assist in Management of Symptomatic Cerebral Vasospasm After Subarachnoid Hemorrhage
Authors
Tatsushi Mutoh
Tatsuya Ishikawa
Akifumi Suzuki
Nobuyuki Yasui
Publication date
01-12-2010
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 3/2010
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-010-9383-9

Other articles of this Issue 3/2010

Neurocritical Care 3/2010 Go to the issue

Practical Pearl

Advanced Imaging Assessment of Posterior Circulation Stroke Before and After Endovascular Intervention

Original Article

Left Ventricular Dysfunction and Cerebral Infarction from Vasospasm After Subarachnoid Hemorrhage

Original Article

Intensive Versus Conventional Insulin Therapy in Critically Ill Neurologic Patients

Original Article

Intensive Insulin Therapy in the Neurocritical Care Setting is Associated with Poor Clinical Outcomes

Original Article

A Comparison of EMG and Muscle Biopsy in ICU Weakness

Practical Pearl

Theophylline for Bradycardia Secondary to Cervical Spinal Cord Injury